Targeting MAPK4 emerges as a promising therapy for prostate cancer
Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.
Read more
Prostate Cancer
The N-terminal domain of the androgen receptor is at the heart of its action
Detailed 3-D studies reveal how the androgen receptor is put together as a functional complex that drives prostate cancer.
Read more
Making ‘sense’ of the ‘cart before the horse’ in mammalian cells
A fusion gene is a new gene made by joining parts of two different genes. The current thought is that fusion genes can happen in
Read more
2017 Michael E. DeBakey M.D. Award for Research Excellence
The five winners of this year’s Michael E. DeBakey M.D. Award for Research Excellence exemplify the breadth and depth of scientific research at Baylor College
Read more
New oncogene MNX1 contributes to higher incidence of prostate cancer among African American men
Genetic factors can explain, at last in part, the higher incidence of prostate cancer among African American men compared with men of other ethnic groups.
Read more
Prostate cancer: What you need to know
During the month of September, Baylor College of Medicine will be partnering with the Blue Cure Foundation for its annual prostate cancer awareness campaign, Light
Read more
Altered metabolism in castration-resistant prostate cancer may point to new therapies
Advanced prostate cancer is usually treated by removing androgen, the male hormone that helps it grow. Although initially effective, this treatment often leads to the
Read more
Mouse model shows that Notch activation can drive metastatic prostate cancer
Nearly 200 thousand men are diagnosed with prostate cancer every year. Most of the deaths associated with prostate cancer occur in advanced stages of the
Read more
Baylor College of Medicine lights up blue in honor of Prostate Cancer Awareness Month
September officially kicks off National Prostate Cancer Awareness Month, and in a show of support for increased awareness, education, research and clinical advances, the Baylor
Read more